KAUST researchers introduce deepBlastoid, an AI platform automating and standardizing classification of human blastoids from brightfield images with high accuracy and efficiency.
Key Details
- 1deepBlastoid uses a ResNet-18 architecture to classify human blastoid images in five categories.
- 2The curated dataset includes 17,133 brightfield images, with 2,407 expert-labeled.
- 3Achieved up to 97% accuracy by combining the base model (87%) with a Confidence Rate metric for expert fallback.
- 4Processes 273.6 images per second—1,000 times faster than human experts.
- 5Tool validated in drug dose optimization and safety assessment use cases.
- 6Publicly available tools and dataset support global research customization.
Why It Matters
DeepBlastoid exemplifies the potential of AI-powered image analysis for scalable, objective, and reproducible evaluation in developmental biology—a workflow parallel to emerging radiology and digital pathology automation. Its open-source tools may inspire similar strategies for image-intensive tasks in radiology and pathology.
Source
EurekAlert
Related News
•EurekAlert
AI Tool Predicts Financial Toxicity Risk in Cancer Patients
Researchers developed a machine learning model to proactively identify cancer patients at high risk of financial stress from treatment.
•EurekAlert
Researchers Develop All-Optical Synapse for Neuromorphic Imaging Systems
A new artificial synapse, controlled entirely by light, enables in-sensor neuromorphic processing for more efficient and noise-resistant imaging systems.
•EurekAlert
AI-Simulation Approach Achieves 90% Faster Brain MRI with Minimal Data
A simulation-based AI method can reconstruct brain MRI scans with only 10% of the usual data, greatly reducing scan times.